These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 22064328)

  • 1. Specialty outpatient care of diabetic patients in Poland--are we far from treatment targets? Rationale, design, and preliminary results of the OPTIMO study.
    Jankowski M; Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Mejza F; Jaeschke R; Sieradzki J; Gajewski P
    Pol Arch Med Wewn; 2011 Nov; 121(11):375-8. PubMed ID: 22064328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of patients with type 2 diabetes of short duration in Poland: Rationale, design and preliminary results of the ARETAEUS1 study.
    Bała MM; Płaczkiewicz-Jankowska E; Topór-Madry R; Leśniak W; Wiercińska E; Szczepaniak P; Jaeschke R; Sieradzki J; Grzeszczak W; Banasiak W;
    Pol Arch Med Wewn; 2009 Sep; 119(9):533-40. PubMed ID: 19776697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and treatment goals in Polish patients with type 2 diabetes of short duration: results of the ARETAEUS2-Grupa study.
    Bała MM; Płaczkiewicz-Jankowska E; Leśniak W; Topór-Mądry R; Michałejko M; Jankowski M; Strzeszyński L; Sieradzki J; Czupryniak L;
    Pol Arch Med Wewn; 2013; 123(11):573-81. PubMed ID: 24241157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors control in Polish patients with type 2 diabetes within the first two years of diagnosis: results of the ARETAEUS1 study.
    Bała MM; Leśniak W; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jaeschke R; Sieradzki J; Grzeszczak W; Banasiak W;
    Kardiol Pol; 2011; 69(12):1249-57. PubMed ID: 22219100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes control in type 2 diabetic subjects treated in primary health care--how far is from life to standards?].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2008; 65(6):277-82. PubMed ID: 18853658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is newly diagnosed type 2 diabetes treated according to the guidelines? Results of the Polish ARETAEUS1 study.
    Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Leśniak W; Jaeschke R; Sieradzki J; Grzeszczak W; Banasiak W;
    Pol Arch Med Wewn; 2011; 121(1-2):7-17. PubMed ID: 21346692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus related treatment goals: awareness and attainment in the Ife-Ijesa zone of south-western Nigeria.
    Kolawole BA; Adegbenro C; Ayoola ZO; Opebiyi B
    Afr J Med Med Sci; 2005 Dec; 34(4):389-94. PubMed ID: 16752671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3ST-POL trial: standards of statin use in Poland in the context of the European Society of Cardiology guidelines.
    Sliz D; Mamcarz A; Filipiak KJ; Siebert J; Naruszewicz M
    Pol Arch Med Wewn; 2010 Sep; 120(9):328-33. PubMed ID: 20864905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with clinical practice guidelines for type 2 diabetes in rural patients: treatment gaps and opportunities for improvement.
    Toth EL; Majumdar SR; Guirguis LM; Lewanczuk RZ; Lee TK; Johnson JA
    Pharmacotherapy; 2003 May; 23(5):659-65. PubMed ID: 12741441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs.
    Stacy TA; Egger A
    J Manag Care Pharm; 2006; 12(9):745-51. PubMed ID: 17249907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of the quality of ambulatory care in type 2 diabetes mellitus].
    Majkowska L; Tejchman K; Slozowski P; Majchrzycka I; Lisienko J; Bielewska K; Sikorska P; Franków M
    Pol Arch Med Wewn; 2004 May; 111(5):579-87. PubMed ID: 15508809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial.
    Kirwin JL; Cunningham RJ; Sequist TD
    J Manag Care Pharm; 2010 Mar; 16(2):104-13. PubMed ID: 20178395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic care in Norwegian general practice. A report of current status from Salten and some regions in Rogaland].
    Claudi T; Cooper J; Skogøy K; Hausken MF; Melbye H
    Tidsskr Nor Laegeforen; 1997 Oct; 117(25):3661-4. PubMed ID: 9417661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis of the implementation of guidelines for type 2 diabetes control developed by Diabetes Poland: what increase in costs is justified by clinical results?
    Szmurło D; Schubert A; Kostrzewska K; Ryś P; Skrzekowska-Baran I
    Pol Arch Med Wewn; 2011 Oct; 121(10):345-50. PubMed ID: 22045095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients.
    Crivera C; Suh DC; Huang ES; Cagliero E; Grant RW; Vo L; Shin HC; Meigs JB
    Curr Med Res Opin; 2006 Nov; 22(11):2301-11. PubMed ID: 17076990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diabetes mellitus--physicians' adherence to clinical guidelines in Norway.
    Hetlevik I; Holmen J; Midthjell K
    Scand J Prim Health Care; 1997 Dec; 15(4):193-7. PubMed ID: 9444723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the relationship between a chronic disease care management program and california pay-for-performance diabetes care cholesterol measures in one medical group.
    Cutler TW; Palmieri J; Khalsa M; Stebbins M
    J Manag Care Pharm; 2007 Sep; 13(7):578-88. PubMed ID: 17874864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.